Haven Capital Group, Inc.

Position in BMY — Bristol Myers Squibb Co

CIK 2055804 CAMARILLO, CA

Position in BMY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$343,299

-$18,053 QoQ

Shares Held

5,958

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

#1,782

of 2,506 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Haven Capital Group, Inc. holds $6,551,690 across 4 Drug Manufacturers - General names. BMY ranks #3 (5.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	22,119	$5,566,025
2	GILD	Gilead Sciences, Inc.	2,730	$344,908
3	BMY	Bristol Myers Squibb Co This page	5,958	$343,299
4	LLY	ELI LILLY & Co	248	$297,458

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$343,299	5,958	0.0%	Shares	Sole	2026-08-14
2026-03-31	$361,352	5,958	-1.1%	Shares	Sole	2026-04-20
2025-12-31	$324,880	6,023	-23.2%	Shares	Defined	2026-01-15
2025-09-30	$353,538	7,839	0.0%	Shares	Defined	2025-11-12
2025-06-30	$362,867	7,839	-9.5%	Shares	Defined	2025-08-14
2025-03-31	$528,417	8,664	-4.5%	Shares	Defined	2025-05-15
2024-12-31	$513,338	9,076	—	Shares	Sole	2025-02-10
No filing history on record for this holder in this stock.